Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerPierre-Étienne Heudel, Jean-Luc Soubirou, Sylvie Chabaud et al.|ESMO Open|2021Cited by 35
Sunitinib en rechallenge dans le cancer du rein métastatique–Résultats de l’étude RESUME–P. Gimel, Stéphane Oudard, Christine Chevreau et al.|The French Journal of Urology|2014Cited by 0